Korean Circulation Journal

  • 제53권5호
  • /
  • Pages.328-330
  • /
  • 2023
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Current Trends and Movements in Managing Pulmonary Arterial Hypertension in Korea

  • Jaeho Seung (Division of Cardiology, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Cardiovascular Center, Seoul St. Mary's Hospital) ;
  • Hun-Jun Park (Division of Cardiology, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Cardiovascular Center, Seoul St. Mary's Hospital)
  • 투고 : 2023.03.01
  • 심사 : 2023.03.05
  • 발행 : 2023.05.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

과제정보

The authors received no financial support for the research, authorship, and/or publication of this article.

참고문헌

  1. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913. 
  2. Maron BA, Hess E, Maddox TM, et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program. Circulation 2016;133:1240-8. 
  3. Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA 2022;327:1379-91. 
  4. Galie N, Barbera JA, Frost AE, et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015;373:834-44. 
  5. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9. 
  6. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest 2012;142:448-56. 
  7. Jang AY, Lee H, Kim HC, Chung JW. Epidemiology of PAH in Korea: an analysis of the national health insurance data, 2002-2018. Korean Circ J 2023;53:313-27.
  8. Lim SS, Lee W, Kim YK, et al. The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015. Orphanet J Rare Dis 2019;14:49. 
  9. Lee JH, Hwang KK. End-of-life care for end-stage heart failure patients. Korean Circ J 2022;52:659-79. 
  10. Oh S, Jung JH, Ahn KJ, et al. Stem cell and exosome therapy in pulmonary hypertension. Korean Circ J 2022;52:110-22.